Jan 1, 2025 05:46AM
Jun 16, 2023 06:00AM
Jun 15, 2023 08:00PM
May 25, 2023 07:00PM
May 25, 2023 04:31PM
May 25, 2023 04:30PM
Jan 23, 2023 03:00AM Takeda To Acquire Exclusive Worldwide (ex-China) License of HUTCHMED’s Fruquintinib, a Highly Selective, Oral VEGFR1/2/3 Tyrosine Kinase Inhibitor
Dec 16, 2022 06:27AM
Aug 8, 2021 08:00PM
Aug 8, 2021 08:00PM
Jul 28, 2021 07:00AM
Jul 23, 2021 07:00AM
Jun 30, 2021 05:00AM
Jun 23, 2021 10:22AM HUTCHMED Announces Pricing of Global Offering
Jun 17, 2021 07:30PM
Mar 24, 2021 09:30AM
Aug 6, 2020 04:05PM
Jul 30, 2020 08:47AM
Feb 6, 2020 02:58AM
Feb 6, 2020 02:58AM
Jan 23, 2020 05:54AM Hutchison China MediTech (HCM) Prices 4.4M ADS Offering at $25/ADS
Jan 23, 2020 03:06AM
Jan 22, 2020 05:42AM
Jan 21, 2020 06:46PM
Sep 30, 2019 09:12AM
Sep 30, 2019 07:16AM
Jun 28, 2019 06:02AM
Jun 28, 2019 05:33AM Chi-Med Announces Pricing of Upsized U.S. Public Secondary Offering of American Depositary Shares
Jun 27, 2019 05:39PM
Jun 27, 2019 05:37PM
Mar 10, 2019 10:00PM
Mar 12, 2018 04:01AM
Oct 30, 2017 11:45AM
Oct 27, 2017 07:26AM
Oct 26, 2017 06:25AM Hutchison China MediTech (HCM) Prices 9.886M ADS at $26.50/Sh
Oct 25, 2017 11:56PM
Oct 24, 2017 04:33PM
Oct 24, 2017 04:31PM
Dec 20, 2016 03:13AM
Dec 14, 2016 03:05AM
Aug 9, 2016 03:52AM
Apr 13, 2016 11:55AM Hutchison China MediTech Limited Announces Exercise of Overallotment Option

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All